# Specific Clinical Experience Investigation for Long-term Use of Exenatide (Byetta Subcutaneous Injection)

> **NCT01817569** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 2948 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01817569
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02-13
- **Primary completion:** 2019-10-03
- **Final completion:** 2019-10-03
- **Target enrollment:** 2948 (ACTUAL)
- **Last updated:** 2020-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01817569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01817569, "Specific Clinical Experience Investigation for Long-term Use of Exenatide (Byetta Subcutaneous Injection)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01817569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*